Yesterday, Reuters reported that Cigna is in talks to sell its Medicare Advantage line of business. Upon the release of the news, Cigna's stock price was down nearly 4% at points and ended the day down 3.85%. As other insurers (namely Humana) aim to get out of their commercial business because Medicare Advantage was much more profitable, how is it that Cigna was unable to make their plans as profitable as they would have liked? Matthew Handley and Fulcrum Strategies CEO Ron Howrigon (also a former Cigna executive) discuss. Reuters - Cigna explores shedding Medicare Advantage Follow Matthew on X and LinkedIn. Follow Ron on LinkedIn. Subscribe and have every episode delivered to your email inbox!
The FLATLINING Podcast from Fulcrum Strategies
The FLATLINING Podcast from Fulcrum Strategies brings you great healthcare news analysis and discussion each week from industry experts who know their way around politics, economics, and a doctor’s office. Questions about payor issues, Medicaid expansion, or the No Surprises Act? We’ve got you covered. New episodes drop every Wednesday morning.
The FLATLINING Podcast from Fulcrum Strategies brings you great healthcare news analysis and discussion each week from industry experts who know their way around politics, economics, and a doctor’s office. Questions about payor issues, Medicaid expansion, or the No Surprises Act? We’ve got you covered. New episodes drop every Wednesday morning.Listen on
Substack App
RSS Feed
Appears in episode
Fulcrum Strategies
Recent Episodes
Share this post